Gentile Carlyn Patterson, Shah Ryan, Marquez De Prado Blanca, Raj Nichelle, Szperka Christina L, Hershey Andrew D, Aguirre Geoffrey K
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
bioRxiv. 2025 May 1:2025.04.30.650986. doi: 10.1101/2025.04.30.650986.
Eighty percent of youth with migraine report photophobia. It is unknown if photophobia leads to light avoidant behavior, and if such behaviors worsen light sensitivity and disrupt sleep. Recently developed wearable, continuous light loggers allow us to address these open questions. We conducted a pilot study to determine the feasibility of measuring light exposure using wearable light loggers in youth with migraine.
Youth 10 - 21 years old with a headache-specialist confirmed ICHD-3 diagnosis of migraine were recruited from CHOP headache clinics. Each participant recorded 7 consecutive days of light logging data from the ActLumus device worn as a pendant around the neck paired with a text-based daily migraine symptom diary during a typical school week between November and March 2024. Validated questionnaires were used to capture any headache and bad headache frequency, headache-related disability, visual sensitivity, fear-of-pain, and sleep disturbance and impairment. Percent time spent within recommended light exposure levels was calculated for the day, 3 hours prior to bedtime, and night. Power analysis was calculated to determine sample size needed for group comparison of baseline characteristics across light intensity and light timing metrics to aid in the design of larger studies.
Twenty youth with a median age 17 years [IQR 16, 19], 70% of whom were female completed 7 days of continuous light logger recording and daily headache diary. Data completion rates were high with 136/140 (97.1%) useable days of light logger data, and 100% compliance on the daily headache diary. Participant feedback on the study was positive; 85% would recommend the study to others. On average, participants received recommended light exposure during only 14.5% +/- SD 7.0 of daylight hours. By contrast, participants were more consistently below the recommended maximum light levels 3 hours prior to bed (77.5% +/- 21.6 of the time), and at night (99.1% +/- 2.9 of the time). Youth with chronic migraine (i.e., at least 15 headache days and 8 bad headache days per month) had daily light exposure patterns that were phase shifted 60 minutes later as compared to participants with non-chronic migraine. Power analyses suggest that future tests for differences in light exposure between migraine-characteristic groups (e.g., differing by headache frequency, severity, or disability) will require sample sizes on the order of 50 to 150 to reach 80% power with an alpha of 0.05.
Measuring daily light exposure is feasible in pediatric populations with photophobia and reveals intriguing trends in youth with migraine that warrant further study.
80%的偏头痛青少年报告有畏光症状。尚不清楚畏光是否会导致避光行为,以及此类行为是否会加重光敏感性并干扰睡眠。最近开发的可穿戴式连续光记录器使我们能够解决这些悬而未决的问题。我们进行了一项试点研究,以确定在偏头痛青少年中使用可穿戴光记录器测量光照暴露的可行性。
从CHOP头痛诊所招募10 - 21岁、经头痛专科医生确诊为国际头痛疾病分类第三版(ICHD-3)偏头痛的青少年。在2024年11月至3月的一个典型上学周期间,每位参与者连续7天记录佩戴在脖子上作为吊坠的ActLumus设备的光照数据,并结合基于文本的每日偏头痛症状日记。使用经过验证的问卷来记录任何头痛和严重头痛的频率、与头痛相关的残疾、视觉敏感性、疼痛恐惧以及睡眠障碍和损害。计算出一天、睡前3小时和夜间处于推荐光照暴露水平内的时间百分比。进行了功效分析,以确定跨光照强度和光照时间指标进行基线特征组间比较所需的样本量,以帮助设计更大规模的研究。
20名青少年,中位年龄17岁[四分位间距16, 19],其中70%为女性,完成了7天的连续光记录器记录和每日头痛日记。数据完成率很高,有136/140(97.1%)天的光记录器数据可用,且每日头痛日记的依从率为100%。参与者对该研究的反馈是积极的;85%的人会向他人推荐该研究。平均而言,参与者在白天仅有14.5%±标准差7.0的时间接受推荐的光照暴露。相比之下,参与者在睡前3小时(77.5%±21.6的时间)和夜间(99.1%±2.9的时间)更持续低于推荐的最大光照水平。与非慢性偏头痛参与者相比,患有慢性偏头痛(即每月至少15天头痛且8天严重头痛)的青少年的每日光照暴露模式相位延迟了60分钟。功效分析表明,未来针对偏头痛特征组(例如按头痛频率、严重程度或残疾程度不同)之间光照暴露差异的测试,将需要50至150左右的样本量,以在α为0.05时达到80%的功效。
在有畏光症状的儿科人群中测量每日光照暴露是可行的,并揭示了偏头痛青少年中有趣的趋势,值得进一步研究。